Join
Live feed
·
INSIDERFilingvia Quantisnow
Eiger BioPharmaceuticals Inc. logo

SEC Form 4: Apelian David sold $49,030 worth of shares (5,000 units at $9.81) as part of a pre-agreed trading plan, decreasing direct ownership by 31% to 11,000 units

ByQuantisnow·Wall Street's wire, on your screen.
EIGR· Eiger BioPharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EIGR (Eiger BioPharmaceuticals Inc.) and more on Quantisnow.